Cognitive Life Sciences Ltd
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Cognipride-MV2 Tablet SR is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet SR
Cognipride-MV2 Tablet SR is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Cognipride-MV2 Tablet SR is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Cognipride-MV2 Tablet SR.
Cognipride-MV2 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Cognipride-MV2 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Cognipride-MV2 Tablet SR is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Cognipride-MV2 Tablet SR contains Glimepiride, Metformin and Voglibose. It is used to treat type 2 diabetes mellitus (DM). This combination improves blood glucose levels in adults when taken with a healthy diet and regular exercise. Glimepiride increases insulin release from the pancreas, Metformin lowers glucose production in the liver, and Voglibose inhibits alpha-glucosidase activity to lower postprandial glucose levels. This medication is not indicated for type 1 diabetes treatment.
Possible side effects include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection. Seek immediate medical attention for any severe or persistent symptoms.
Avoid use if you have a known allergy to the medication's components. This medication should also be avoided in individuals with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis including diabetic ketoacidosis.
No. Combining Cognipride-MV2 Tablet SR with alcohol may lower blood sugar levels and increase the risk of lactic acidosis.
Yes, Cognipride-MV2 Tablet SR can cause hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. These effects are more likely to occur if you miss meals, drink alcohol, exercise excessively or take other antidiabetic medications with it. Regular monitoring of your blood sugar levels is essential.
Keep this medication in its original packaging, tightly sealed. Store according to the product's label instructions. Do not use expired medicine. Do not give this medicine to pets, children, or other individuals.